Skip to content
Trial Agents

Colibri Scientific

Colibri Scientific is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
1recorded service labels
1trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A Phase 3b/4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex (EpiCom)

Sponsor Jazz Pharmaceuticals Research UK Limited

Start (EU)
Latest update
Estimated end
Operational learnings available3 trial-level findings · Read insights
  • Enrollment was concentrated in the United States (53 of 79 participants), with 12 enrolled in Poland, 9 in Canada, and 5 in the United Kingdom.
  • Optional adult self-report assessments had limited analyzed samples: 3 participants each for the ASR and PSQI, and 2 participants for PROMIS 1-4 positive affect.
  • The protocol phase was revised from Phase 4 to Phase 3b/4 because EPIDIOLEX was not approved in Canada and some European countries.

These findings describe the trial, not the service provider’s performance or responsibility.

Questions about this trial experience

What services are recorded for Colibri Scientific?

The 2026-10-09 snapshot links Colibri Scientific to 5 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Colibri Scientific?

The most frequently recorded therapeutic areas are Genetic and Congenital Disorders, Neurology, Solid Tumor Oncology. Recorded phases include Phase 3, Phase 2, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Colibri Scientific conducted?

The linked trials record locations in 8 countries, including Spain, France, Belgium, Germany, Denmark. These are trial locations, not confirmed office locations or countries where Colibri Scientific delivered services.

What can this page tell me about Colibri Scientific's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Colibri Scientific. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Colibri Scientific Limited

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.